Ocular Therapeutix (OCUL) Amortizatization of Intangibles (2015 - 2019)
Ocular Therapeutix's quarterly Amortizatization of Intangibles came in at $143000.0 in Q2 2019, down 23.53% quarter-over-quarter from $187000.0 in Q1 2019.
Ocular Therapeutix has reported Amortizatization of Intangibles for 4 years, with the latest figure at $143000.0 in Q2 2019.
- For the quarter ending Q2 2019, Amortizatization of Intangibles changed N/A year-over-year to $143000.0; the trailing twelve-month figure through Jun 2019 stood at $330000.0 (changed N/A YoY), and the FY2017 full-year result was $17000.0, down 90.86% from the prior year.
- Amortizatization of Intangibles for Q2 2019 stood at $143000.0, down from $187000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $470000.0 in Q4 2015, with the low at -$148000.0 in Q3 2015.
- Average Amortizatization of Intangibles over 4 years is $68000.0, with a median of $16500.0 recorded in 2016.
- Peak annual rise in Amortizatization of Intangibles reached 677.78% in 2016, while the deepest fall reached 97.23% in 2016.
- Tracing OCUL's Amortizatization of Intangibles over 4 years: stood at $470000.0 in 2015, then sank by 97.23% to $13000.0 in 2016, then tumbled by 53.85% to $6000.0 in 2017, then jumped by 2283.33% to $143000.0 in 2019.
- The last three Amortizatization of Intangibles figures came in at $143000.0 (Q2 2019), $187000.0 (Q1 2019), and $6000.0 (Q2 2017), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 143,000.00 |
| Jun 30, 2019 | 143,000.00 |
| Mar 31, 2019 | 187,000.00 |
| Mar 31, 2019 | 187,000.00 |
| Jun 30, 2017 | 6,000.00 |
| Jun 30, 2017 | 6,000.00 |
| Mar 31, 2017 | 11,000.00 |
| Mar 31, 2017 | 11,000.00 |
| Dec 31, 2016 | 13,000.00 |
| Dec 31, 2016 | 13,000.00 |
| Sep 30, 2016 | 20,000.00 |
| Sep 30, 2016 | 20,000.00 |
| Jun 30, 2016 | 49,000.00 |
| Jun 30, 2016 | 49,000.00 |
| Mar 31, 2016 | 104,000.00 |
| Mar 31, 2016 | 104,000.00 |
| Dec 31, 2015 | 470,000.00 |
| Dec 31, 2015 | 470,000.00 |
| Sep 30, 2015 | -148,000.00 |
| Sep 30, 2015 | -148,000.00 |
| Jun 30, 2015 | -21,000.00 |
| Jun 30, 2015 | -21,000.00 |
| Mar 31, 2015 | -18,000.00 |
| Mar 31, 2015 | -18,000.00 |